Maxi Novel
About:
Maxi Novel specializes in the fields of oral combination of tumor immunity, targeted drugs, and chemotherapy drugs.
Website: http://www.maxinovel.com
Top Investors: Dyee Capital, Longpan Investment, Youchoose Capital, Baifu Health
Description:
Maxi Novel specializes in the fields of oral combination of tumor immunity, targeted drugs, and chemotherapy drugs.
Total Funding Amount:
300M CNY
Headquarters Location:
Beijing, Beijing, China
Founded Date:
2016-01-01
Contact Email:
maxi(AT)maxinovel.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-10-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai